Advertisement
Advertisement

NGNE

NGNE logo

Neurogene, Inc. Common Stock

17.58
USD
Sponsored
-1.31
-6.93%
Jan 30, 15:58 UTC -5
Closed
exchange

After-Market

17.62

+0.04
+0.23%

NGNE Earnings Reports

Positive Surprise Ratio

NGNE beat 26 of 39 last estimates.

67%

Next Report

Date of Next Report
Mar 23, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.12
Implied change from Q3 25 (Revenue/ EPS)
--
/
+13.13%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+13.13%

Neurogene, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, NGNE reported earnings of -0.99 USD per share (EPS) for Q3 25, beating the estimate of -1.27 USD, resulting in a 22.35% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -14.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -1.12 USD, with revenue projected to reach -- USD, implying an increase of 13.13% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Neurogene, Inc. Common Stock reported EPS of -$0.99, beating estimates by 22.35%, and revenue of $0.00, 0% as expectations.
The stock price moved down -14.04%, changed from $26.49 before the earnings release to $22.77 the day after.
The next earning report is scheduled for Mar 23, 2026.
Based on 8 analysts, Neurogene, Inc. Common Stock is expected to report EPS of -$1.12 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement